CbdMD Inc (YCBD)
cbdMD, Inc. is a common stock listing on the NYSE under the symbol YCBD. The company develops, markets, and distributes cannabidiol-based consumer products in the United States and international markets. Its portfolio includes CBD oils, gummies, capsules, soft-gels, topicals, and functional formulations under the cbdMD brand, along with hemp-derived compliant Delta-9 THC products. Through Paw CBD, it also sells products for dogs and cats, including tinctures, chews, and topicals. Additional offerings include non-cannabinoid functional ingredients under the ATRx brand and hemp-derived solutions under Herbal Oasis. cbdMD serves retailers and health and pet channels through direct-to-consumer sales, e-commerce platforms, online marketplaces, and wholesale distribution. The company is based in Charlotte, North Carolina, and previously operated under the name Level Brands, Inc. before adopting the cbdMD name in May 2019.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-YCBD
|
$0.61
|
21.4% Upside
|
Undervalued
|
$2
|
300.0% Upside
|
Bargain
|
Fair
|
0.0%
|
December 18, 2026
|
0.7x
|
0.3x
|
5.603 M
|
4.998 M
|
30.3%
|
97.3%
|
-21.0
|
-4.2%
|
78.2%
|
